Nearly three years since the start of the COVID-19 pandemic and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, viruses are still circulating across the globe. Scientists are investigating how they work and how best to treat the viruses.
To do further research, University Hospitals (UH) Cleveland Medical Center’s team received a two year $200,000 grant from the American Lung Association (ALA) to study the long term consequences and outcomes of COVID-19 and other viruses.
The two year grant from ALA will provide researchers at UH with resources to:
- Gain a new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention
- Identify host factors that alter response to infections
- Investigate individual, regional, or social factors increasing or decreasing the community spread of COVID-19 and other respiratory viruses
- Learn how epidemiological approaches are needed to understand COVID-19 and other respiratory viruses while tracking cases
“There is an urgent need to better understand the pathobiology and long term and immediate clinical implications of SARS-CoV-2 virtual infection that leads to COVID’s death rates,” said Kenneth E. Remy MD, Division of Pulmonary Critical Care and Pediatric Critical Care at University Hospitals and PI for the study.